Increased Endogenous Activity of the Renin-Angiotensin System Reduces Infarct Size in the Rats with Early Angiotensin II-dependent Hypertension which Survive the Acute Ischemia/Reperfusion Injury.

Frontiers in Pharmacology
Zuzana HuskováJan Neckář

Abstract

We investigated the role of the interaction between hypertension and the renin-angiotensin system in the pathophysiology of myocardial ischemia/reperfusion injury. We hypothesized that in the early phase of angiotensin II (ANG II)-dependent hypertension with developed left ventricular hypertrophy, cardioprotective mechanism(s) are fully activated. The experiments were performed in transgenic rats with inducible hypertension, noninduced rats served as controls. The early phase of ANG II-dependent hypertension was induced by five-days (5 days) dietary indole-3-carbinol administration. Cardiac hypertrophy, ANG II and ANG 1-7 levels, protein expression of their receptors and enzymes were determined. Separate groups were subjected to acute myocardial ischemia/reperfusion injury, and infarct size and ventricular arrhythmias were assessed. Induced rats developed marked cardiac hypertrophy accompanied by elevated ANG levels. Ischemia/reperfusion mortality was significantly higher in induced than noninduced rats (52.1 and 25%, respectively). The blockade of AT1 receptors with losartan significantly increased survival rate in both groups. Myocardial infarct size was significantly reduced after 5 days induction (by 11%), without changes a...Continue Reading

References

Sep 1, 1988·Cardiovascular Research·D Garcia-DoradoJ Solares
Jun 1, 1997·Coronary Artery Disease·A NakanoK Shimamoto
Oct 9, 1998·Cardiovascular Research·Y M PintoD Ganten
Jun 8, 2001·News in Physiological Sciences : an International Journal of Physiology Produced Jointly by the International Union of Physiological Sciences and the American Physiological Society·L. Gabriel NavarKenneth D. Mitchell
Jul 13, 2001·The Journal of Biological Chemistry·S KantachuvesiriJ J Mullins
Jan 28, 2003·Pflügers Archiv : European journal of physiology·Linda Jane Mullins, John Mullins
Feb 20, 2003·European Journal of Pharmacology·Alexandra OudotLuc Rochette
Oct 8, 2003·British Journal of Pharmacology·Robert E WiddopTracey A Gaspari
Oct 15, 2003·Hypertension·Mahmood S Mozaffari, Stephen W Schaffer
Aug 3, 2004·Kidney & Blood Pressure Research·Pavel DvorákLudek Cervenka
Jul 4, 2006·Physiological Reviews·Martin PaulReinhold Kreutz
Jul 28, 2006·American Journal of Physiology. Cell Physiology·Puja K Mehta, Kathy K Griendling
Apr 9, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Seiji MatsuhisaToshiji Iwasaka
Sep 15, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Jörg PetersRainer Rettig
Feb 23, 2010·Drug Discovery Today·Lijun ShiLubo Zhang
Aug 12, 2010·Advances in Experimental Medicine and Biology·Po Sing Leung
Apr 21, 2012·Journal of Magnetic Resonance Imaging : JMRI·Barbara S PetersRainer Rettig
Aug 3, 2012·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Anders HostrupThomas Jespersen
Oct 12, 2012·Journal of Cardiovascular Pharmacology·Claudia WagnerChristof Weinbrenner
Mar 7, 2014·Clinical Science·Clare A McKinneyStuart A Nicklin
Oct 21, 2015·Redox Biology·D Neil Granger, Peter R Kvietys
Dec 18, 2015·Heart·Heerajnarain BulluckDerek J Hausenloy
Feb 7, 2016·Archives of Biochemistry and Biophysics·Lyudmila P DolgachevaEgor A Turovsky

❮ Previous
Next ❯

Software Mentioned

- Pad Prism Pad
Graph

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.